Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» DCVax-L
DCVax-L
Northwest Bio Receives SEC Subpoena and Other Awful Nuggets From New 10-K
TheStreet.com
Tue, 04/18/17 - 09:40 am
Northwest Biotherapeutics
SEC
DCVax-L
Northwest Bio Spikes on Lifting of Clinical Hold
Investopedia
Tue, 02/7/17 - 06:16 pm
Northwest Biotherapeutics
DCVax-L
glioblastoma multiforme
brain cancer
Northwest Bio CEO: Brain Tumor Vaccine Study Enrollment Still Suspended
TheStreet.com
Thu, 09/17/15 - 09:50 am
Northwest Biotherapeutics
vaccines
DCVax-L
brain tumors
Northwest Bio Forced to Temporarily Halt Study of Brain Tumor Vaccine
TheStreet.com
Mon, 08/24/15 - 11:42 am
Northwest Biotherapeutics
DCVax-L
vaccines
brain tumors
Northwest Bio's Cell Therapy Named 'Promising Innovative Medicine'
Drug Discovery and Development
Tue, 09/16/14 - 01:46 pm
Northwest Biotherapeutics
cell therapy
innovation
UK
DCVax-L
5 Companies Developing New Cancer Drugs
Yahoo/Benzinga
Tue, 08/19/14 - 04:40 pm
cancer
OncoSec
ImmunoCellular
CDX-011
Celldex Therapeutics
DCVax-L
Northwest Biotherapeutics
Inovio
Risk of Pivotal Study Failure Rises for NewLink and Northwest Bio
TheStreet.com
Fri, 03/7/14 - 12:28 pm
NewLink Genetics
Northwest Biotherapeutics
DCVax-L
HyperAcute Pancreas
Panel recommends Northwest Bio brain-cancer trial continue
Yahoo/Reuters
Fri, 03/7/14 - 09:21 am
Northwest Biotherapeutics
glioblastoma multiforme
clinical trials
DCVax-L
Tiny Northwest Biotherapeutics aims to dominate brain cancer
Yahoo/Reuters
Wed, 02/26/14 - 08:41 am
Northwest Biotherapeutics
DCVax-L
brain cancer